login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
GENERATION BIO CO (GBIO) Stock News
NASDAQ:GBIO -
US37148K1007
-
Common Stock
5.98
USD
0 (0%)
Last: 9/4/2025, 9:55:54 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GBIO Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Yahoo Finance
- Mentions:
PFE
LLY
PGEN
Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial
22 days ago - By: Benzinga
- Mentions:
ARCT
LIXT
DERM
EDIT
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
4 months ago - By: Benzinga
Where Generation Bio Stands With Analysts
22 days ago - By: The Motley Fool
Generation Bio Posts 81% Q2 Revenue Drop
23 days ago - By: Zacks Investment Research
- Mentions:
OCS
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
23 days ago - By: Generation Bio Co.
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
23 days ago - By: Zacks Investment Research
- Mentions:
OBIO
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
2 months ago - By: Generation Bio Co.
Generation Bio Announces 1-for-10 Reverse Stock Split
2 months ago - By: Generation Bio Co.
Generation Bio Announces 1-for-10 Reverse Stock Split
2 months ago - By: Generation Bio Co.
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Generation Bio Co.
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Generation Bio Co.
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
4 months ago - By: Zacks Investment Research
- Mentions:
CTKB
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: Generation Bio Co.
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
5 months ago - By: Generation Bio Co.
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
5 months ago - By: Generation Bio Co.
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
6 months ago - By: Generation Bio Co.
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
6 months ago - By: Generation Bio Co.
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
6 months ago - By: Generation Bio Co.
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
6 months ago - By: Generation Bio Co.
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
8 months ago - By: Generation Bio Co.
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
8 months ago - By: Generation Bio Co.
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
Please enable JavaScript to continue using this application.